SCHEMBL563608

SCHEMBL563608

O=c1ccc2nc3ccc(-c4ccccc4)cc3oc-2c1

nearest known ligand 0.63

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
APP P05067 13/20 0.63
CYP1A2 P05177 1/20 0.55
GPR119 Q8TDV5 3/20 0.48
L3MBTL1 Q9Y468 2/20 0.43
GAA P10253 1/20 0.43
KDM4E B2RXH2 1/20 0.43
MEN1 O00255 1/20 0.43
ALDH1A1 P00352 1/20 0.43
ALPL P05186 1/20 0.43
POLB P06746 1/20 0.43
ALPI P09923 1/20 0.43
MAPT P10636 1/20 0.43
ALPG P10696 1/20 0.43
RECQL P46063 1/20 0.43
RAB9A P51151 1/20 0.43
KMT2A Q03164 1/20 0.43
PGR P06401 1/20 0.41
PLA2G2A P14555 1/20 0.40
PLA2G4A P47712 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8067 0.82 APP (0.65) APPCYP1A2L3MBTL1GAAKDM4E
SCHEMBL1096453 0.80 APP (0.63) APPCYP1A2L3MBTL1GAAKDM4E
Water SCHEMBL1094033 0.80 APP (0.63) APPCYP1A2L3MBTL1GAAKDM4E
SCHEMBL10145489 0.80 APP (0.59) APPCYP1A2L3MBTL1GAAKDM4E
SCHEMBL1094100 0.80 APP (0.59) APPCYP1A2GPR119L3MBTL1KDM4E
SCHEMBL23806150 0.79 L3MBTL1 (0.47) APPCYP1A2L3MBTL1GAAKDM4E
SCHEMBL5085776 0.79 APP (0.61) APPCYP1A2L3MBTL1KDM4EMEN1
SCHEMBL1635563 0.78 APP (0.68) APPCYP1A2L3MBTL1GAAKDM4E
SCHEMBL8066 0.78 APP (1.00) APPCYP1A2MEN1POLBKMT2A
SCHEMBL14243596 0.78 APP (0.68) APPCYP1A2L3MBTL1KDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9216974-B2 Phenoxazine derivatives and methods of use thereof WASHINGTON UNIVERSITY (US) 2015-12-22 US disclosed
US-9115099-B2 Phenoxazine derivatives and methods of use thereof WASHINGTON UNIVERSITY (US) 2015-08-25 US disclosed
US-20150175589-A1 PHENOXAZINE DERIVATIVES AND METHODS OF USE THEREOF UNIV WASHINGTON (US) 2015-06-25 US disclosed
US-20140221647-A1 PHENOXAZINE DERIVATIVES AND METHODS OF USE THEREOF WASHINGTON UNIVERSITY 2014-08-07 US disclosed
US-8735575-B2 Phenoxazine derivatives and methods of use thereof WASHINGTON UNIVERSITY (US) 2014-05-27 US disclosed
US-20120035359-A1 PHENOXAZINE DERIVATIVES AND METHODS OF USE THEREOF THE WASHINGTON UNIVERSITY (US) 2012-02-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140221647-A1 PHENOXAZINE DERIVATIVES AND METHODS OF USE THEREOF PPOX, CYP4Z1, PRDX2 APP 3242/4885CYP1A2 12/4885GPR119 4334/4885
US-20150175589-A1 PHENOXAZINE DERIVATIVES AND METHODS OF USE THEREOF PPOX, CYP4Z1, PRDX2 APP 3242/4885CYP1A2 12/4885GPR119 4334/4885
US-20120035359-A1 PHENOXAZINE DERIVATIVES AND METHODS OF USE THEREOF PPOX, CYP4Z1, PRDX2 APP 3242/4885CYP1A2 12/4885GPR119 4334/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.